Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders

Blood. 2001 Apr 1;97(7):2130-6. doi: 10.1182/blood.v97.7.2130.

Abstract

In a previous study, it was shown that the Kaposi sarcoma-associated herpesvirus (KSHV) was specifically associated with monotypic (IgMlambda) plasmablasts in multicentric Castleman disease (MCD). The plasmablasts occur as isolated cells in the mantle zone of B-cell follicles but may form microlymphoma or frank plasmablastic lymphoma. To determine the clonality and cellular origin of the monotypic plasmablasts, the rearranged Ig genes in 13 patients with KSHV-related MCD, including 8 cases with microlymphomas and 2 with frank lymphomas, were studied. To investigate the role of the interleukin 6 (IL-6) receptor signaling in the pathogenesis of MCD and associated lymphoproliferative disorders, viral IL-6 and human IL-6 receptor expression was examined. KSHV-positive plasmablasts were polyclonal in MCD-involved lymphoid tissues in all cases and microlymphomas in 6 of 8 cases. Monoclonal KSHV-positive plasmablasts were seen in microlymphomas of 2 cases and in both frank lymphomas. Despite their mature phenotype, KSHV-positive plasmablasts did not harbor somatic mutations in the rearranged Ig genes, indicating origination from naive B cells. Viral IL-6 was expressed in 10% to 15% of KSHV-positive plasmablasts, whereas the human IL-6 receptor was expressed in most KSHV-positive cells. Thus, KSHV infects monotypic but polyclonal naive B cells and is associated with a range of lymphoproliferative disorders from polyclonal isolated plasmablasts and microlymphomas to monoclonal microlymphoma and frank plasmablastic lymphomas in MCD patients. Activation of the IL-6 receptor signaling pathway may play a role in differentiation of KSHV-infected naive B cells into plasmablasts and development of lymphoproliferative lesions. (Blood. 2001;97:2130-2136)

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Viral
  • B-Lymphocyte Subsets / chemistry
  • B-Lymphocyte Subsets / pathology
  • B-Lymphocyte Subsets / virology*
  • Biomarkers
  • Castleman Disease / complications
  • Castleman Disease / pathology
  • Castleman Disease / virology*
  • Clone Cells / chemistry
  • Clone Cells / pathology
  • Clone Cells / virology
  • DNA, Viral / analysis
  • HIV Infections / complications
  • Herpesviridae Infections / complications
  • Herpesviridae Infections / pathology
  • Herpesviridae Infections / virology*
  • Herpesvirus 4, Human / isolation & purification
  • Herpesvirus 8, Human / pathogenicity*
  • Herpesvirus 8, Human / physiology
  • Humans
  • Immunoglobulin M / analysis*
  • Immunoglobulin lambda-Chains / analysis*
  • In Situ Hybridization
  • Interleukin-6 / analysis
  • Lymphoma, AIDS-Related / chemistry
  • Lymphoma, AIDS-Related / pathology
  • Lymphoma, AIDS-Related / virology
  • Lymphoproliferative Disorders / pathology
  • Lymphoproliferative Disorders / virology*
  • Nuclear Proteins / analysis
  • Plasma Cells / chemistry
  • Plasma Cells / pathology
  • Plasma Cells / virology*
  • Receptors, Interleukin-6 / analysis
  • Viral Proteins / analysis

Substances

  • Antigens, Viral
  • Biomarkers
  • DNA, Viral
  • Immunoglobulin M
  • Immunoglobulin lambda-Chains
  • Interleukin-6
  • Nuclear Proteins
  • Receptors, Interleukin-6
  • Viral Proteins
  • latency-associated nuclear antigen